VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 356 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2016. The put-call ratio across all filers is 1.00 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $6,056,000 | -23.2% | 417,100 | +29.9% | 0.21% | +28.2% |
| Q3 2016 | $7,885,000 | +92.1% | 321,200 | +57.6% | 0.16% | +18.1% |
| Q2 2016 | $4,104,000 | +54.8% | 203,752 | +102.0% | 0.14% | +76.9% |
| Q1 2016 | $2,652,000 | +53.5% | 100,852 | +1059.2% | 0.08% | +62.5% |
| Q1 2015 | $1,728,000 | -87.8% | 8,700 | -92.8% | 0.05% | -95.0% |
| Q4 2013 | $14,111,000 | -18.1% | 120,200 | -27.2% | 0.96% | -38.1% |
| Q3 2013 | $17,235,000 | -48.0% | 165,200 | -57.1% | 1.56% | -54.2% |
| Q2 2013 | $33,141,000 | – | 385,000 | – | 3.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |